Logo image of AMC.DE

ALBEMARLE CORP (AMC.DE) Stock Fundamental Analysis

FRA:AMC - US0126531013 - Common Stock

69.67 EUR
+1.56 (+2.29%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMC. AMC was compared to 68 industry peers in the Chemicals industry. While AMC seems to be doing ok healthwise, there are quite some concerns on its profitability. AMC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AMC has reported negative net income.
AMC had a positive operating cash flow in the past year.
Of the past 5 years AMC 4 years were profitable.
AMC had a positive operating cash flow in each of the past 5 years.
AMC.DE Yearly Net Income VS EBIT VS OCF VS FCFAMC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

The Return On Assets of AMC (-6.34%) is worse than 76.47% of its industry peers.
With a Return On Equity value of -10.70%, AMC is not doing good in the industry: 73.53% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
AMC.DE Yearly ROA, ROE, ROICAMC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

AMC's Gross Margin of 7.76% is on the low side compared to the rest of the industry. AMC is outperformed by 85.29% of its industry peers.
AMC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AMC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
AMC.DE Yearly Profit, Operating, Gross MarginsAMC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

AMC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMC remains at a similar level compared to 1 year ago.
AMC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AMC has been reduced compared to a year ago.
AMC.DE Yearly Shares OutstandingAMC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMC.DE Yearly Total Debt VS Total AssetsAMC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.65, we must say that AMC is in the distress zone and has some risk of bankruptcy.
AMC's Altman-Z score of 1.65 is on the low side compared to the rest of the industry. AMC is outperformed by 66.18% of its industry peers.
AMC has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
AMC has a better Debt to Equity ratio (0.31) than 66.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.65
ROIC/WACCN/A
WACC7.95%
AMC.DE Yearly LT Debt VS Equity VS FCFAMC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.31 indicates that AMC has no problem at all paying its short term obligations.
AMC's Current ratio of 2.31 is fine compared to the rest of the industry. AMC outperforms 72.06% of its industry peers.
AMC has a Quick Ratio of 1.47. This is a normal value and indicates that AMC is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.47, AMC is doing good in the industry, outperforming 70.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.47
AMC.DE Yearly Current Assets VS Current LiabilitesAMC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The earnings per share for AMC have decreased strongly by -155.42% in the last year.
Looking at the last year, AMC shows a very negative growth in Revenue. The Revenue has decreased by -33.05% in the last year.
AMC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.42% yearly.
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%

3.2 Future

Based on estimates for the next years, AMC will show a very strong growth in Earnings Per Share. The EPS will grow by 63.36% on average per year.
Based on estimates for the next years, AMC will show a quite strong growth in Revenue. The Revenue will grow by 11.24% on average per year.
EPS Next Y29.4%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
EPS Next 5Y63.36%
Revenue Next Year-9.94%
Revenue Next 2Y-1.64%
Revenue Next 3Y4.19%
Revenue Next 5Y11.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMC.DE Yearly Revenue VS EstimatesAMC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AMC.DE Yearly EPS VS EstimatesAMC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

AMC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AMC is valuated quite expensively with a Price/Forward Earnings ratio of 380.57.
70.59% of the companies in the same industry are cheaper than AMC, based on the Price/Forward Earnings ratio.
AMC is valuated expensively when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 380.57
AMC.DE Price Earnings VS Forward Price EarningsAMC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

73.53% of the companies in the same industry are cheaper than AMC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.16
AMC.DE Per share dataAMC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AMC's earnings are expected to grow with 56.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.61%
EPS Next 3Y56.79%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.04%, AMC has a reasonable but not impressive dividend return.
AMC's Dividend Yield is comparable with the industry average which is at 3.10.
Compared to an average S&P500 Dividend Yield of 2.41, AMC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

On average, the dividend of AMC grows each year by 13.04%, which is quite nice.
Dividend Growth(5Y)13.04%
Div Incr Years3
Div Non Decr Years3
AMC.DE Yearly Dividends per shareAMC.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AMC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of AMC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-32.53%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
AMC.DE Yearly Income VS Free CF VS DividendAMC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ALBEMARLE CORP

FRA:AMC (9/5/2025, 7:00:00 PM)

69.67

+1.56 (+2.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners98.79%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap8.20B
Analysts68.13
Price Target70.66 (1.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend2.27
Dividend Growth(5Y)13.04%
DP-32.53%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.46%
Min EPS beat(2)69.72%
Max EPS beat(2)113.21%
EPS beat(4)2
Avg EPS beat(4)-30.22%
Min EPS beat(4)-249.28%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.6%
EPS beat(12)7
Avg EPS beat(12)-3.87%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)8.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)1.74%
PT rev (3m)-5.29%
EPS NQ rev (1m)-22.01%
EPS NQ rev (3m)-2036.34%
EPS NY rev (1m)-6.56%
EPS NY rev (3m)-12.71%
Revenue NQ rev (1m)1.34%
Revenue NQ rev (3m)-1.83%
Revenue NY rev (1m)2.13%
Revenue NY rev (3m)1.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 380.57
P/S 1.91
P/FCF N/A
P/OCF 12.25
P/B 0.93
P/tB 1.15
EV/EBITDA 26.16
EPS(TTM)-2.33
EYN/A
EPS(NY)0.18
Fwd EY0.26%
FCF(TTM)-1.33
FCFYN/A
OCF(TTM)5.69
OCFY8.16%
SpS36.43
BVpS74.71
TBVpS60.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.76%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 7.46
Cap/Depr 146.27%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 182.86%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.47
Altman-Z 1.65
F-Score4
WACC7.95%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y29.4%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
EPS Next 5Y63.36%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%
Revenue Next Year-9.94%
Revenue Next 2Y-1.64%
Revenue Next 3Y4.19%
Revenue Next 5Y11.24%
EBIT growth 1Y79.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.47%
EBIT Next 3Y43.09%
EBIT Next 5Y36.66%
FCF growth 1Y-118.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.5%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%